EvolveImmune Therapeutics
Stella Martomo, PhD has extensive work experience in the field of immunology and translational sciences. Stella currently holds the position of Director of Translational Sciences at EvolveImmune Therapeutics since December 2022. Prior to this, they served as the Immuno-Oncology Lead for Research/Preclinical/Early Clinical Development at Kadmon, a Sanofi Company from October 2011 to November 2022. From September 2007 to October 2011, they worked in the field of Translational Immunology at Columbia University Irving Medical Center. Stella began their career in 2002 as a Postdoctoral Fellow in Immuno-biology at The National Institutes of Health, where they worked until September 2007.
Stella Martomo, PhD has a Bachelor of Science (BS) degree from the University of Victoria. Stella also holds a Doctor of Philosophy (PhD) degree from Oregon State University.
This person is not in any offices
EvolveImmune Therapeutics
2 followers
EvolveImmune Therapeutics is a next-generation immunotherapy platform company based in Farmington and Branford, CT. Building upon research that originates from the Sidi Chen Lab at Yale University, EvolveImmune is leveraging a novel in vivo target discovery platform to develop a broad portfolio of first-in-class molecules for unmet needs in oncology and autoimmune diseases.